非对位选择级联双Michael加入通道桥接香豆素、辛哚和螺旋辛哚:一种可持续合成抗癌分子的策略。

IF 3.6 4区 医学 Q2 CHEMISTRY, MEDICINAL ChemMedChem Pub Date : 2024-12-16 DOI:10.1002/cmdc.202400946
Shravani Battula, Haripriya Bhumannagari, S S S S Sudha Ambadipudi, Sai Balaji Andugulapati, Kiranmai Nayani
{"title":"非对位选择级联双Michael加入通道桥接香豆素、辛哚和螺旋辛哚:一种可持续合成抗癌分子的策略。","authors":"Shravani Battula, Haripriya Bhumannagari, S S S S Sudha Ambadipudi, Sai Balaji Andugulapati, Kiranmai Nayani","doi":"10.1002/cmdc.202400946","DOIUrl":null,"url":null,"abstract":"<p><p>An efficient and concise synthesis of highly functionalized bridged coumarins has been developed through a diastereoselective double Michael addition reaction of p-quinols with various 4-hydroxy coumarins under catalyst-free conditions in H<sub>2</sub>O-DMSO (8 : 2). The method has been applied to oxindoles for the synthesis of a variety of bridged-oxindoles and bridged-spiroxindoles in presence of a DABCO base using H<sub>2</sub>O-EtOH (8 : 2) as solvent medium. The strategy is simple, highly atom economical as there is no by-product and environmentally benign (E-factor=0.1-0.9). The synthesized compounds were screened against triple-negative breast cancers and found that bridged coumarin (3 a) and oxindole (5 d) compounds exhibit potent anti-cancer activity at 6.6 and 8.8 μM (IC<sub>50</sub>) concentrations respectively. Further analysis revealed that 3 a and 5 d caused elevated early and total apoptosis by arresting the MDA-MB-468 cells in G2/M phase of the cell cycle. Overall, our results demonstrate that bridged coumarin (3 a) and oxindole (5 d) compounds-based approach attenuates the cancer progression and may pave a path for the translational outcome.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":" ","pages":"e202400946"},"PeriodicalIF":3.6000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diastereoselective Cascade Double Michael Addition to Access Bridged Coumarins, Oxindoles and Spirooxindoles: A Sustainable Strategy for Synthesis of Anticancer Molecules.\",\"authors\":\"Shravani Battula, Haripriya Bhumannagari, S S S S Sudha Ambadipudi, Sai Balaji Andugulapati, Kiranmai Nayani\",\"doi\":\"10.1002/cmdc.202400946\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>An efficient and concise synthesis of highly functionalized bridged coumarins has been developed through a diastereoselective double Michael addition reaction of p-quinols with various 4-hydroxy coumarins under catalyst-free conditions in H<sub>2</sub>O-DMSO (8 : 2). The method has been applied to oxindoles for the synthesis of a variety of bridged-oxindoles and bridged-spiroxindoles in presence of a DABCO base using H<sub>2</sub>O-EtOH (8 : 2) as solvent medium. The strategy is simple, highly atom economical as there is no by-product and environmentally benign (E-factor=0.1-0.9). The synthesized compounds were screened against triple-negative breast cancers and found that bridged coumarin (3 a) and oxindole (5 d) compounds exhibit potent anti-cancer activity at 6.6 and 8.8 μM (IC<sub>50</sub>) concentrations respectively. Further analysis revealed that 3 a and 5 d caused elevated early and total apoptosis by arresting the MDA-MB-468 cells in G2/M phase of the cell cycle. Overall, our results demonstrate that bridged coumarin (3 a) and oxindole (5 d) compounds-based approach attenuates the cancer progression and may pave a path for the translational outcome.</p>\",\"PeriodicalId\":147,\"journal\":{\"name\":\"ChemMedChem\",\"volume\":\" \",\"pages\":\"e202400946\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2024-12-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ChemMedChem\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/cmdc.202400946\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemMedChem","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/cmdc.202400946","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

在无催化剂条件下,对喹啉与各种4-羟基香豆素在H2O-DMSO中进行非对对选择性双Michael加成反应,制备了高效、简洁的高功能化桥接香豆素。该方法已应用于氧吲哚,在DABCO碱存在下,以H2O-EtOH(8:2)为溶剂介质合成了多种桥接氧吲哚和桥接螺吲哚。该策略简单,原子经济性高,因为没有副产品,对环境无害(E-factor = 0.1-0.9)。对合成的化合物进行了抗三阴性乳腺癌的筛选,发现桥接香豆素(3a)和氧吲哚(5d)化合物分别在6.6µM和8.8µM (IC50)浓度下具有较强的抗癌活性。进一步分析发现,3a和5d通过使MDA-MB-468细胞处于细胞周期的G2/M期而导致早期和总凋亡增加。总的来说,我们的研究结果表明,基于桥接香豆素(3a)和氧吲哚(5d)化合物的方法可以减缓癌症的进展,并可能为转化结果铺平道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Diastereoselective Cascade Double Michael Addition to Access Bridged Coumarins, Oxindoles and Spirooxindoles: A Sustainable Strategy for Synthesis of Anticancer Molecules.

An efficient and concise synthesis of highly functionalized bridged coumarins has been developed through a diastereoselective double Michael addition reaction of p-quinols with various 4-hydroxy coumarins under catalyst-free conditions in H2O-DMSO (8 : 2). The method has been applied to oxindoles for the synthesis of a variety of bridged-oxindoles and bridged-spiroxindoles in presence of a DABCO base using H2O-EtOH (8 : 2) as solvent medium. The strategy is simple, highly atom economical as there is no by-product and environmentally benign (E-factor=0.1-0.9). The synthesized compounds were screened against triple-negative breast cancers and found that bridged coumarin (3 a) and oxindole (5 d) compounds exhibit potent anti-cancer activity at 6.6 and 8.8 μM (IC50) concentrations respectively. Further analysis revealed that 3 a and 5 d caused elevated early and total apoptosis by arresting the MDA-MB-468 cells in G2/M phase of the cell cycle. Overall, our results demonstrate that bridged coumarin (3 a) and oxindole (5 d) compounds-based approach attenuates the cancer progression and may pave a path for the translational outcome.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ChemMedChem
ChemMedChem 医学-药学
CiteScore
6.70
自引率
2.90%
发文量
280
审稿时长
1 months
期刊介绍: Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. Contents ChemMedChem publishes an attractive mixture of: Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews.
期刊最新文献
Replacing a Cereblon Ligand by a DDB1 and CUL4 Associated Factor 11 (DCAF11) Recruiter Converts a Selective Histone Deacetylase 6 PROTAC into a pan-degrader. An Effective Reaction-based Virtual Screening Method to Discover new CDK8 Ligands. Metal-Catalyzed Cross-Coupling for the Synthesis of β-Lactam Drugs and Related Chemical Probes. Front Cover: [18F]NP3-627, a Candidate PET Imaging Agent Targeting the NLRP3 Inflammasome in the Central Nervous System (ChemMedChem 4/2025) Cover Feature: Design, Synthesis, and Anti-Prostate Cancer Potential of 2-(4-Nitrobenzyl) Malonates In Vitro and DAL Acute Oral Toxicity Assessment In Vivo (ChemMedChem 4/2025)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1